Article Versions Notes

Poggesi A, Barbato C, Galmozzi F, Camilleri E, Cesari F, Chiti S, Diciotti S, Galora S, Giusti B, Gori AM, et al. Role of Biological Markers for Cerebral Bleeding Risk STRATification in Patients with Atrial Fibrillation on Oral Anticoagulants for Primary or Secondary Prevention of Ischemic Stroke (Strat-AF Study): Study Design and Methodology. Medicina. 2019; 55(10):626. https://doi.org/10.3390/medicina55100626

Poggesi, Anna, Carmen Barbato, Francesco Galmozzi, Eleonora Camilleri, Francesca Cesari, Stefano Chiti, Stefano Diciotti, Silvia Galora, Betti Giusti, Anna Maria Gori, and et al. 2019. "Role of Biological Markers for Cerebral Bleeding Risk STRATification in Patients with Atrial Fibrillation on Oral Anticoagulants for Primary or Secondary Prevention of Ischemic Stroke (Strat-AF Study): Study Design and Methodology" Medicina 55, no. 10: 626. https://doi.org/10.3390/medicina55100626

Poggesi, A., Barbato, C., Galmozzi, F., Camilleri, E., Cesari, F., Chiti, S., Diciotti, S., Galora, S., Giusti, B., Gori, A. M., Marzi, C., Melone, A., Mistri, D., Pescini, F., Pracucci, G., Rinnoci, V., Sarti, C., Fainardi, E., Marcucci, R., & Salvadori, E. (2019). Role of Biological Markers for Cerebral Bleeding Risk STRATification in Patients with Atrial Fibrillation on Oral Anticoagulants for Primary or Secondary Prevention of Ischemic Stroke (Strat-AF Study): Study Design and Methodology. Medicina, 55(10), 626. https://doi.org/10.3390/medicina55100626